Results
-
FibroGen Reports First Quarter 2025 Financial Results
5/13
-
Quarterly Report for Quarter Ending March 31, 2025 (Form 10-Q)
5/12
-
Additional Proxy Soliciting Materials (Form DEFA14A)
4/25
-
Proxy Statement (Form DEF 14A)
4/25
-
Preliminary Proxy Statement (Form PRE 14A)
4/17
-
Amendments to Bylaws (Form 8-K)
4/4
-
3/28
-
Statement of Changes in Beneficial Ownership (Form 4)
3/25
-
Statement of Changes in Beneficial Ownership (Form 4)
3/24
-
Fourth Quarter and Full Year 2024 Financial Results Presentation
3/17